Myocardial infarction without coronary artery atherosclerosis (MINOCA) — scientific interest or practical need?
Journal Title: Серце і судини - Year 2019, Vol 0, Issue 3
Abstract
In recent years, much attention has been paid to the diagnosis and treatment of myocardial infarction (MI) without obstructive coronary artery atherosclerosis (MINOCA). According to statistics, the average prevalence of MINOCA is 6 — 8 % of all cases of MI. The diagnostic criteria for MINOCA are: presence of criteria for MI, absence of obstructive coronary artery disease according to data of coronary angiography (including angiographic stenosis < 50 %); no other cause of myocardial damage. According to the consensus of the American Heart Association (AHA) (2019), the diagnosis of MINOCA includes 3 stages. In the first stage, reanalysis of the clinical situation should be performed to rule out alternative diagnoses. In the second stage, it is necessary to evaluate the functional reserve of blood flow, to exclude non‑ischemic mechanisms of damage with the help of instrumental methods of research. The third stage is carried out in a specialized clinic, where the etiological factors of MI are verified. The article presents a clinical case of MI in a patient of 26 years of age. The diagnosis was confirmed by an increased level of troponin, changes in the electrocardiogram, echocardiographic examination and magnetic resonance imaging. With CA performed within 12 hours from the onset of the disease, hemodynamically significant coronary artery constrictions were not detected. During the laboratory examination, a significant increase in the level of homocysteine was found — 69 μmol/l (norm < 12.0 μmol/l). Given the weighted heredity, the emergence of MI at a young age, the absence of triggering factors (medications, stress, excessive physical activity, trauma, etc.) and diseases (diabetes, systemic connective tissue disease), an increased level of homocysteine, the role of thrombosis is highly probable. The patient is advised to consult a hematologist to identify hereditary thrombophilia as the cause of thrombosis (while taking antiplatelet/anticoagulant therapy performance of the tests and their interpretation are incorrect). It is recommended to take an angiotensin‑converting enzyme inhibitor, clopidogrel 75 mg/day, rivaroxaban 2.5 mg 2 times a day; β‑blocker, statins. Given the high level of homocysteine, the patient should follow a diet rich in folic acid‑rich foods.
Authors and Affiliations
L. O. Tkachenko, O. A. Epantschintsevа, M. V. Stan, S. M. Sagura
Keywords
Related Articles
- EP ID EP673890
- DOI 10.30978/HV2019-3-60
- Views 144
- Downloads 0
Register of percutaneous coronary interventions: expanded comparative analysis of results of 2016 and 20 17. From reperfusion paradox to decrease of mortality
Ukrainian Association of Interventional Cardiology established Percutaneous Coronary Interventions Registry (PCI Registry) in 2010. The first protocol was filled on 12.04.2010. By now (23.07.2018, 17 h 58 min) the Regist...
Doppler flowmetry in determination and evaluation of blood flow characteristics in anterior abdominal wall vessels during lipoabdominoplasty
The aim — to determine the possibility of using Doppler blood flow in the vessels of the anterior abdominal wall in order to improve the results and develop new methods for treating patients with cosmetic defects of the...
Clinical and anamnestic characteristics of patients with acute pulmonary embolism
The aim — to analyze the features of the course and the main factors of development of pulmonary embolism (PE). Materials and methods. During the period from January 1, 2014 until July 1, 2018, 774 patients with acute p...
Phenotype-oriented approach to clinical evaluation of patients with chronic heart failure with preserved left ventricular ejection fraction
The aim — to establish the clinical significance of the phenotype‑based approach to assessing patients with verified heart failure (HF) with preserved left ventricular (LV) ejection (LV) fraction and its relationship wit...
Register of percutaneous coronary interventions. Are changes for 2015 — 2018 a casual splash of activities or system transformations?
The Register of Percutaneous Coronary Interventions (PCI) was created in 2010 by the all‑Ukrainian non‑governmental organization «Association of Interventional Cardiologists of Ukraine». As of 03.08.2019, 19 h 48 min, 12...